How is the Opus Genetics Inc. today?

The Opus Genetics Inc. today is trading in the down by 0.00% at 1.00.

How has Opus Genetics Inc. performed historically?

The Opus Genetics Inc. is currently trading down 0.00% on an intraday basis in the past week the index fell -1.96%. The index has been down -2.91% in the past quarter and fell -40.48% in the past year. You can view this in the overview section.

What is Opus Genetics Inc. Annual Revenue?

Opus Genetics Inc. Annual Revenue fell 42.3%, in the last year to $10.99 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Opus Genetics Inc. Annual Net Profit?

Opus Genetics Inc. Annual Net Profit fell 476.13% in the last year to $57.53 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Opus Genetics Inc. Price to Earning Ratio?

Opus Genetics Inc. Price to Earning Ratio is -1.02, which is negative.

What is Opus Genetics Inc. Stock Price?

Opus Genetics Inc. Stock Price fell 40.48% and underperformed its sector by 77.39% in the past year.

What is Opus Genetics Inc. Quarterly Revenue?

Opus Genetics Inc. Quarterly Revenue rose 155.41% YoY to $4.37 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Opus Genetics Inc. Quarterly Net profit?

Opus Genetics Inc. Quarterly Net profit fell 15.31% YoY to $8.19 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Opus Genetics Inc. Return on Equity(ROE)?

Opus Genetics Inc. Return on Equity(ROE) for the last financial year was -203.19%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Opus Genetics Inc. Mutual Fund Holding?

Opus Genetics Inc. Mutual Fund Holding decreased by 0.82% in the last quarter to 6.83.

What is Opus Genetics Inc. Institutional Holding?

Opus Genetics Inc. Institutional Holding increased by 24.26% in the last quarter to 32.18.

Opus Genetics Inc. XNAS: IRD

Opus Genetics Inc. Live Share Price Today, Share Analysis and Chart

Name: Opus Genetics Inc.: Is Infosys Ltd. worth buying?
Item: Opus Genetics Inc.
Rating: 1.31241675
Author: Trendlyne DVM scores

about

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline include...

1.00 0.00 (0.00%)

54.13% Fall from 52W High

73,075 XNAS Volume

XNAS 30 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Opus Genetics Inc. is on 11 Jun 2025 for the purpose of Ocuphire Pharma Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

12.2 / 100

Technically Neutral

40.3 / 100

1Yr Price target upside is 633%

3 analysts

Opus Genetics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Opus Genetics Inc. Live Share Price Today, Share Analysis and Chart

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline include...

54.13% Fall from 52W High

SWOT Analysis

Opus Genetics Inc. Live Price Chart

Opus Genetics Inc. FAQ

How is Opus Genetics Inc. today?

Opus Genetics Inc. today is trading in the red, and is down by 0.00% at 1.00.

How has Opus Genetics Inc. performed historically?

Opus Genetics Inc. is currently trading down 0.00% on an intraday basis. In the past week the stock fell -1.96%. stock has been down -2.91% in the past quarter and fell -40.48% in the past year. You can view this in the overview section.